Serum Analysis of Coagulation Factors in IPF and NSIP

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Antiphospholipid Antibody Syndrome

(2011) Nikhil A Sangle et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease

(2011) Galina S. Bogatkevich et al.   ARTHRITIS AND RHEUMATISM

High-resolution CT of complications of idiopathic fibrotic lung disease

(2011) C R Lloyd et al.   BRITISH JOURNAL OF RADIOLOGY

Prise en charge des exacerbations aiguës de fibrose pulmonaire idiopathique

(2011) J.-M. Naccache et al.   REVUE DES MALADIES RESPIRATOIRES

The roles of thrombin and protease-activated receptors in inflammation

(2011) Liang Ma et al.   Seminars in Immunopathology

MicroRNAs in idiopathic pulmonary fibrosis

(2011) Kusum V. Pandit et al.   Translational Research

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis

(2010) Harold R. Collard et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Sleep-disordered Breathing and Prothrombotic Biomarkers

(2010) Reena Mehra et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Exacerbaciones agudas de la fibrosis pulmonar idiopática

(2010) José Manuel Valle Vázquez et al.   MEDICINA CLINICA

Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts

(2009) Galina S. Bogatkevich et al.   ARTHRITIS AND RHEUMATISM

Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?

(2008) R C Chambers   BRITISH JOURNAL OF PHARMACOLOGY